Cargando…

Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease

The combination of an initial clinical approach aimed at evaluating the early risk of mortality with subsequent diagnostic and therapeutic approaches articulated on the overall patient’s profile is recommended in acute pulmonary embolism (PE). The presence of pulmonary hypertension associated with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palazzini, Massimiliano, Dardi, Fabio, Magnani, Ilenia, Guarino, Daniele, Galie’, Nazzareno, Manes, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	CCC 2023 - State of the Art Cardiology Supplement Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120940/ https://www.ncbi.nlm.nih.gov/pubmed/37091640 http://dx.doi.org/10.1093/eurheartjsupp/suad080

Ejemplares similares

How much does the presentation pattern of atrial fibrillation affect thrombo-embolic risk and mortality?
por: Turturiello, Dario, et al.
Publicado: (2023)

Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors
por: Dardi, Fabio, et al.
Publicado: (2023)

A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines
por: Dardi, Fabio, et al.
Publicado: (2021)

GPs Meet Rare Lung Disorders Task Force factsheet: pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2015)

Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses
por: Galiè, Nazzareno, et al.
Publicado: (2010)

Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
por: Ferri, Nicola, et al.
Publicado: (2023)

Treatment of multiple valve disease: surgery, structural intervention, or both?
por: Berti, Sergio, et al.
Publicado: (2023)

In search of new gatekeepers: coronary CT (Computed Tomography) in acute coronary syndrome
por: Schillaci, Matteo, et al.
Publicado: (2023)

Long-term follow-up after invasive or conservative management of stable coronary disease: the ISCHEMIA-EXTEND study
por: Bolognese, Leonardo, et al.
Publicado: (2023)

Therapy of Type 2 diabetes: more gliflozines and less metformin?
por: Verdecchia, Paolo, et al.
Publicado: (2023)

How much does hypertension in pregnancy affect the risk of future cardiovascular events?
por: Mureddu, Gian Francesco
Publicado: (2023)

Spontaneous coronary artery dissection: an unpredictable event
por: Smirnova, Alexandra, et al.
Publicado: (2023)

Scenarios in precision medicine: proteomics in heart failure
por: Gentile, Piero, et al.
Publicado: (2022)

Clinical update on pulmonary embolism
por: Duru, Serap, et al.
Publicado: (2013)

Management of massive and nonmassive pulmonary embolism
por: Sekhri, Vishal, et al.
Publicado: (2012)

Nightmare in the ward: difficult Clostridioides infection
por: Tarasi, Agapito
Publicado: (2023)

Takotsubo syndrome: more frequent in women, more dangerous in men
por: Natale, Enrico, et al.
Publicado: (2023)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023)

What is the role of coronary revascularization to recover the contractility of the dysfunctional heart?
por: Vassiliki’ Cousoumbas, Gloria, et al.
Publicado: (2023)

The temptation of anticoagulant therapy after transcatheter aortic valve implantation
por: Gatto, Laura, et al.
Publicado: (2023)

Atrial fibrillation in heart failure: drugs or ablation?
por: Palmas, Francesco, et al.
Publicado: (2023)

Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect?
por: Bisceglia, Irma, et al.
Publicado: (2023)

Sudden death in ischemic heart disease: looking for new predictors: polygenic risk
por: Boccanelli, Alessandro, et al.
Publicado: (2023)

Indications, evidence, and controversy in the closure of the left atrial appendage
por: Patti, Giuseppe, et al.
Publicado: (2023)

Treatment of amyloidosis: present and future
por: Mallus, Maria Teresa, et al.
Publicado: (2023)

The metaverse in medicine
por: Massetti, Massimo, et al.
Publicado: (2023)

Sudden cardiac death in ischaemic heart disease: coronary thrombosis or myocardial fibrosis?
por: Prati, Francesco, et al.
Publicado: (2023)

Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2023)

Treating chronic kidney disease to reduce cardiovascular risk
por: Cice, Gennaro, et al.
Publicado: (2023)

The new in anticoagulation: factor XI inhibitors
por: Muscente, Francesca, et al.
Publicado: (2023)

Acute coronary syndromes: hospital management of dyslipidaemia with proprotein convertase subtilisin/kexin 9 inhibitors: time to act
por: Musumeci, Giuseppe, et al.
Publicado: (2023)

Causes of sudden death
por: De Gaspari, Monica, et al.
Publicado: (2023)

Heart failure therapy: the fifth card
por: Balestrieri, Giulio, et al.
Publicado: (2023)

A focus on the percutaneous therapy of mitral and tricuspid regurgitation
por: Frazzetto, Marco, et al.
Publicado: (2023)

DOACs and rheumatic valvulopathy: always a red light?
por: Rochira, Carla, et al.
Publicado: (2023)

Challenges in cardiology: diagnosis of native and prosthetic valve endocarditis
por: Pepi, Mauro, et al.
Publicado: (2023)

Renal denervation and long-term results
por: Simonetti, Fiorenzo, et al.
Publicado: (2023)

Less sodium and more potassium to reduce cardiovascular risk
por: Muiesan, Maria Lorenza, et al.
Publicado: (2023)

Impact of the exposome on cardiovascular disease
por: Bonanni, Alice, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sunmjptni84mjcrqmese13u50d